Table 4.
Proteins significantly different between controls and patients through Wilcoxon rank-sum testing with p < 0.05 and q < 0.05 of Supplementary File 1.
| Protein | AUC | Protein Ratio | EntrezGene | UniProt | AUC |
|---|---|---|---|---|---|
| RNase1 | 0.87 | FRDA/TIMD3 * | FXN/HAVCR2 * | Q16595/Q8TDQ0 | 0.95 |
| RABP2 | 0.87 | Layilin/CLC4D * | LAYN/CLEC4D * | Q6UX15/Q8WXI8 | 0.94 |
| AIF1L | 0.87 | RNase1/EKI1 | RNASE1/ETNK1 | P07998/Q9HBU6 | 0.94 |
| PXDN | 0.86 | BMPER/TNF sR-I | BMPER/TNFRSF1A | Q8N8U9/P19438 | 0.93 |
| Ephrin-A4 | 0.86 | EphA5/CFTR * | EPHA5/CFTR * | P54756/P13569 | 0.93 |
| TIMD3 | 0.85 | TIMD3/CFTR | HAVCR2/CFTR | Q8TDQ0/P13569 | 0.93 |
| MXRA7 | 0.85 | VIGLN/EphA5 | HDLBP/EPHA5 | Q00341/P54756 | 0.93 |
| TNF sR-I | 0.85 | Keratin-16/CFTR * | KRT16/CFTR * | P08779/P13569 | 0.93 |
| IL-18 BPa | 0.85 | P5CR2/Layilin | PYCR2/LAYN | Q96C36/Q6UX15 | 0.92 |
* Ratios with potential biological relevance.